Navigation Links
AMDL Announces New Corporate Video
Date:6/24/2008

TUSTIN, Calif., June 24 /PRNewswire-FirstCall/ -- AMDL, Inc. (Amex: ADL), http://www.amdl.com, a leader in specialty pharmaceuticals headquartered in Tustin, Ca. with operations in Shenzhen, Jiangxi, and Jilin, China, announced today it has released a new Corporate video which is available for viewing on the Company's website at http://www.amdl.com.

According to Gary Dreher, Chief Executive Officer of AMDL, "We have created a new, three minute company video to highlight AMDL's unique China-centric pharmaceutical business. It also illuminates our significant business prospects." Click on (NEWS at http://www.amdl.com) to view the video.

About AMDL:

AMDL, Inc. is a global specialty pharmaceutical company. The company is headquartered in Tustin, California with operations in Shenzhen, Jiangxi, and Jilin, China. Along with its subsidiary Jade Pharmaceutical Inc. (JPI), AMDL is devoted to the research, development, manufacturing, and marketing of diagnostic, pharmaceutical, nutritional supplement, and cosmetic products currently in China. The company employs approximately 320 people in the U.S. and China. More information about AMDL and its products can be obtained at http://www.amdl.com.

About Jade Pharmaceutical:

JPI has access to the fastest growing pharmaceutical and consumer market in the world: China. AMDL, through its subsidiaries, Jade currently manufactures large volume injection fluids, tablets and other related products, holding licenses for 133 products. It also manufactures 107 generic, over the counter and supplemental pharmaceutical products under certified Chinese Good Manufacturing Practice (CGMP) standards.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements contained in this Document include certain predictions and projections that are forward-looking statements under securities law. These statements involve a number of important risks and uncertainties that could cause actual results to differ materially including, but not limited to, the performance of joint venture partners, as well as other economic, competitive and technological factors involving the Company's operations, markets, services, products and prices. With respect to AMDL Inc., except for the historical information contained herein, the matters discussed in this Document are forward-looking statements involving risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements. Potential risks and uncertainties include, but are not limited to, AMDL Inc.'s operating history, uncertainties related to the Company's access to additional capital, competition and dependence on key management.

Contact: Kristine Szarkowitz

AMDL Communications

206/310-3523

kszarkowitz@amdl.com


'/>"/>
SOURCE AMDL, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
4. HEI, Inc. Announces Sale of RFID Division Assets
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
8. Brooke Franchise Corporation Announces Selected July Results
9. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
11. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... ... February 17, 2017 , ... Like most hospitals across ... Driven in large part by the Hospital Readmission Reduction Program (HRRP), the return of ... focus area for hospitals across the nation. While many providers are struggling to leverage ...
(Date:2/17/2017)... ... 17, 2017 , ... The Mason Pasquin Agency, a Virginia-based ... owners in and around the Hampton Roads metropolitan region, is joining the local ... domestic violence. , There are multiple categories of domestic violence – physical abuse ...
(Date:2/16/2017)... ... February 17, 2017 , ... Harsha ... 10 years of research, development and clinical trials, the founder of Chigurupati Technologies ... patented compound of FDA approved ingredients that when infused into alcohol, protect the ...
(Date:2/16/2017)... ... 17, 2017 , ... Teaching nursing care of vulnerable children is the focus ... is being created with the support of the Hearst Foundations. An initiative of the ... address what has been identified as a critical gap in preparing the next generation ...
(Date:2/16/2017)... Mt. Kisco, New York (PRWEB) , ... February ... ... Westchester Hospital’s (NWH) nursing professionalism, teamwork and superiority in patient care, NWH ... Chair of the Commission on Magnet on Tuesday, January 31, 2017. The American ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... , February 17, 2017 ... the S&P 500 edged lower at the closing bell, ... streak above the 20,000 benchmark. Moreover, five out of ... Taking into consideration yesterday,s market sentiment, Stock-Callers.com assessed the ... & Nephew PLC (NYSE: SNN ), ABIOMED ...
(Date:2/16/2017)... Research and Markets has announced the ... Technologies" report to their offering. ... Traditional medical devices include ... non-drug coated implantables, large endoscopes, needle based drug delivery, lab ... last two to three decades for the treatment and management ...
(Date:2/16/2017)... -- The global preparative and process chromatography market is ... USD 5.49 billion in 2016, at a CAGR of ... the preparative and process chromatography market is segmented into ... chromatography segment is expected to account for the largest ... in this segment can primarily be attributed to the ...
Breaking Medicine Technology: